Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Talbot

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tractJ P Braybrooke, K J O'Byrne, M P Saunders, et al.
British Journal of Cancer|May 3, 2002
Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclinesD C Talbot, V Moiseyenko, S Van Belle, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effectsD J Propper, M P Saunders, A J Salisbury, et al.
British Journal of Cancer|August 28, 2003
A phase 1 study of tazarotene in adults with advanced cancerP H Jones, R D Burnett, I Fainaru, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000D J Propper, J de Bono, A Saleem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumoursD J Propper, J P Braybrooke, D J Taylor, et al.
British Journal of Cancer|June 6, 2000
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancerD J Propper, N C Levitt, K O'Byrne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
British Journal of Cancer|May 27, 2004
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancerP H Jones, K Christodoulos, N Dobbs, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tractJ P Braybrooke, K J O'Byrne, M P Saunders, et al.
British Journal of Cancer|May 3, 2002
Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclinesD C Talbot, V Moiseyenko, S Van Belle, et al.
British Journal of Cancer|May 19, 2011
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerO A Khan, A D Blann, M J Payne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effectsD J Propper, M P Saunders, A J Salisbury, et al.
British Journal of Cancer|August 28, 2003
A phase 1 study of tazarotene in adults with advanced cancerP H Jones, R D Burnett, I Fainaru, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000D J Propper, J de Bono, A Saleem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumoursD J Propper, J P Braybrooke, D J Taylor, et al.
British Journal of Cancer|June 6, 2000
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancerD J Propper, N C Levitt, K O'Byrne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
British Journal of Cancer|May 27, 2004
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancerP H Jones, K Christodoulos, N Dobbs, et al.
Pageof 7